Autologous Immune Cell Therapy – DC-CIK (Stage I to III solid cancer) Regulations of Special Medical Techniques passed
2023.05.06
Cellular therapy program: Autologous Immune Cell Therapy (DC-CIK)
Indications: Ineffective standard treatment of solid cancer (stage I to stage III)
Cancer type: pancreatic cancer, colorectal cancer, liver cancer, lung cancer, melanoma, bladder cancer, and prostate cancer
https://celltherapy.mohw.gov.tw/tech_search_page.htm?id=398